Outpatient Treatment Of Acute Venous Thromboembolism With Rivaroxaban

被引：0
|
作者：
Kline, J. A. [1 ,2 ]
Beam, D. M. [1 ]
Kahler, Z. P. [2 ]
Collins, C. M. [3 ]
机构：
[1] Indiana Univ, Indianapolis, IN 46204 USA
[2] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
[3] Indiana Univ Purdue Univ, Indianapolis, IN 46202 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2015年 / 191卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4864
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A Case of Cerebral Infarction During Treatment With Rivaroxaban for Venous Thromboembolism
    Kitahara, Kanayuki
    Momo, Kenji
    Nimura, Satomi
    Okazaki, Keinosuke
    Suzuki, Norihiro
    Kubota, Yutaro
    Tsunoda, Takuya
    Watanabe, Daishi
    Mizuma, Keita
    Ono, Kenjiro
    Sasaki, Tadanori
    AMERICAN JOURNAL OF THERAPEUTICS, 2022, 29 (06) : E673 - E676
  • [22] Cancer-associated venous thromboembolism: Treatment and prevention with rivaroxaban
    Bauersachs, Rupert
    Khorana, Alok A.
    Lee, Agnes Y. Y.
    Soff, Gerald
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2020, 4 (04) : 532 - 549
  • [23] Effectiveness and Safety of Rivaroxaban in Treatment of Venous Thromboembolism in Cancer Patients
    Win, Khine Z.
    Wilson, Nathan
    Stenehjem, David D.
    Tanner, Natalee
    Rodgers, George M.
    Gilreath, Jeffrey
    BLOOD, 2015, 126 (23)
  • [24] Pharmacokinetic and pharmacodynamic evaluation of rivaroxaban: Considerations for the treatment of venous thromboembolism
    Harder S.
    Thrombosis Journal, 12 (1)
  • [25] Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin
    Prandoni, Paolo
    Lensing, Anthonie W. A.
    Prins, Martin H.
    Gebel, Martin
    Pap, Akos F.
    Homering, Martin
    Bauersachs, Rupert
    Beyer-Westendorf, Jan
    Bounameaux, Henri
    Cohen, Alexander T.
    Davidson, Bruce L.
    van Bellen, Bonno
    Verhamme, Peter
    Wells, Philip S.
    Yuan, Zhong
    Levitan, Bennett
    Weitz, Jeffrey I.
    THROMBOSIS RESEARCH, 2018, 168 : 121 - 129
  • [26] Rivaroxaban in the Treatment of Venous Thromboembolism and the Prevention of Recurrences: A Practical Approach
    Arcelus, Juan I.
    Domenech, Pere
    del Carmen Fernandez-Capitan, Ma
    Guijarro, Ricardo
    Jimenez, David
    Jimenez, Sonia
    Lozano, Francisco S.
    Monreal, Manel
    Nieto, Jose A.
    Paramo, Jose A.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2015, 21 (04) : 297 - 308
  • [27] Enoxaparin Treatment Followed by Rivaroxaban for the Treatment of Acute Lower Limb Venous Thromboembolism: Initial Experience in a Single Center
    Wolosker, Nelson
    Varella, Andrea Y. M.
    Fukuda, Juliana M.
    Teivelis, Marcelo
    Kuzniec, Sergio
    Krutman, Mariana
    Guerra, Joao C. de C.
    Ramacciotti, Eduardo
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2016, 22 (04) : 377 - 380
  • [28] Venous Thromboembolism in Children: The Rivaroxaban Experience
    Spiezia, Luca
    Campello, Elena
    Tormene, Daniela
    Simioni, Paolo
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2024, 50 (06): : 866 - 872
  • [29] A treatment strategy using subcutaneous fondaparinux followed by oral rivaroxaban is effective for treating acute venous thromboembolism
    Kabuki, Takayuki
    Nakanishi, Rine
    Hisatake, Shinji
    Fujii, Takahiro
    Dobashi, Shintaro
    Wakakura, Shingo
    Kiuchi, Shunsuke
    Fujino, Tadashi
    Ikeda, Takanori
    JOURNAL OF CARDIOLOGY, 2017, 70 (1-2) : 163 - 168
  • [30] Healthcare costs associated with rivaroxaban or warfarin use for the treatment of venous thromboembolism
    Coleman, Craig I.
    Baugh, Christopher
    Crivera, Concetta
    Milentijevic, Dejan
    Wang, Sheng-Wei
    Lu, Lang
    Nelson, Winnie W.
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (02) : 200 - 203
12345